BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16283535)

  • 1. Analyzing multi-response data using forcing functions.
    Zhang L; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):283-305. PubMed ID: 16283535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance.
    Zhang L; Beal SL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):387-404. PubMed ID: 15000421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous vs. sequential analysis for population PK/PD data II: robustness of methods.
    Zhang L; Beal SL; Sheinerz LB
    J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):405-16. PubMed ID: 15000422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of pharmacokinetic parameters by orthogonal regression: comparison of four algorithms.
    Tod M; Aouimer A; Petitjean O
    Comput Methods Programs Biomed; 2002 Jan; 67(1):13-26. PubMed ID: 11750944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.
    Sherer EA; Sale ME; Pollock BG; Belani CP; Egorin MJ; Ivy PS; Lieberman JA; Manuck SB; Marder SR; Muldoon MF; Scher HI; Solit DB; Bies RR
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):393-414. PubMed ID: 22767341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.
    Tuk B; Danhof M; Mandema JW
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):39-62. PubMed ID: 9353693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models.
    Välitalo PAJ
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):623-638. PubMed ID: 34159497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of an aerosol screening model for size-resolved urban aerosols.
    Stanier CO; Lee SR;
    Res Rep Health Eff Inst; 2014 Jun; (179):3-79. PubMed ID: 25145039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models.
    Krzyzanski W; Dmochowski J; Matsushima N; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):635-55. PubMed ID: 16941234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods of utilizing baseline values for indirect response models.
    Woo S; Pawaskar D; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2009 Oct; 36(5):381-405. PubMed ID: 19697107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Generalized Speed-Accuracy Response Model for Dichotomous Items.
    van Rijn PW; Ali US
    Psychometrika; 2018 Mar; 83(1):109-131. PubMed ID: 29164449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of prior information to stabilize a population data analysis.
    Gisleskog PO; Karlsson MO; Beal SL
    J Pharmacokinet Pharmacodyn; 2002 Dec; 29(5-6):473-505. PubMed ID: 12795242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of type I error rates for the statistical sub-model in NONMEM.
    Wählby U; Bouw MR; Jonsson EN; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):251-69. PubMed ID: 12449498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A semiparametric approach to physiological flow models.
    Verotta D; Sheiner LB; Ebling WF; Stanski DR
    J Pharmacokinet Biopharm; 1989 Aug; 17(4):463-91. PubMed ID: 2614682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check.
    Yano Y; Beal SL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2001 Apr; 28(2):171-92. PubMed ID: 11381569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nonlinearities and uncorrelated or correlated errors in realistic simulated data on the prediction abilities of augmented classical least squares and partial least squares.
    Melgaard DK; Haaland DM
    Appl Spectrosc; 2004 Sep; 58(9):1065-73. PubMed ID: 15479523
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.